Cited by 47Receptor Mechanisms and SignalingNeuropeptides and Animal PhysiologyCardiovascular, Neuropeptides, and Oxidative Stress Research

Atypical signaling and functional desensitization response of MAS receptor to peptide ligands

Open access
Tirupula, Kalyan C., Desnoyer, Russell, Speth, Robert C., Karnik, Sadashiva S.·2014·PLoS ONE

Abstract

MAS is a G protein-coupled receptor (GPCR) implicated in multiple physiological processes. Several physiological peptide ligands such as angiotensin-(1-7), angiotensin fragments and neuropeptide FF (NPFF) are reported to act on MAS. Studies of conventional G protein signaling and receptor desensitization upon stimulation of MAS with the peptide ligands are limited so far. Therefore, we systematically analyzed G protein signals activated by the peptide ligands. MAS-selective non-peptide ligands that were previously shown to activate G proteins were used as controls for comparison on a common cell based assay platform. Activation of MAS by the non-peptide agonist (1) increased intracellular calcium and D-myo-inositol-1-phosphate (IP1) levels which are indicative of the activation of classical Gαq-phospholipase C signaling pathways, (2) decreased Gαi mediated cAMP levels and (3) stimulated Gα12-dependent expression of luciferase reporter. In all these assays, MAS exhibited strong constitutive activity that was inhibited by the non-peptide inverse agonist. Further, in the calcium response assay, MAS was resistant to stimulation by a second dose of the non-peptide agonist after the first activation has waned suggesting functional desensitization. In contrast, activation of MAS by the peptide ligand NPFF initiated a rapid rise in intracellular calcium with very weak IP1 accumulation which is unlike classical Gαq-phospholipase C signaling pathway. NPFF only weakly stimulated MAS-mediated activation of Gα12 and Gαi signaling pathways. Furthermore, unlike non-peptide agonist-activated MAS, NPFF-activated MAS could be readily re-stimulated the second time by the agonists. Functional assays with key ligand binding MAS mutants suggest that NPFF and non-peptide ligands bind to overlapping regions. Angiotensin-(1-7) and other angiotensin fragments weakly potentiated an NPFF-like calcium response at non-physiological concentrations (≥100 µM). Overall, our data suggest that peptide ligands induce atypical signaling and functional desensitization of MAS.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0103520

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tirupula, K. C., Desnoyer, R., Speth, R. C., & Karnik, S. S.
Affiliations
  • Cleveland Clinic (US)
  • Nova Southeastern University (US)
Corresponding author
Karnik, Sadashiva S.
Venue
PLoS ONE
Published
2014-07-28
Volume
9
Issue
7
Pages
e103520
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2002671750
Cited by
47
References
64
Citations by year
2026: 4 · 2025: 1 · 2024: 5 · 2023: 6 · 2022: 1 · 2021: 8 · 2020: 1 · 2019: 4 · 2018: 5 · 2017: 5 · 2015: 7
FWCI
1.64
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • NSUWorks (Nova Southeastern University) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • Ipsen
  • National Heart, Lung, and Blood Institute (HL115964, R01HL132351, R01HL083243, HL57470, R01HL057470, R01HL115964)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
  • Health Sciences › Medicine › Surgery › Cardiovascular, Neuropeptides, and Oxidative Stress Research
Keywords
Mas receptor, G protein-coupled receptors, peptide ligands, neuropeptide FF, angiotensin-(1-7), Gαq/11 signaling, phospholipase C, Gαi signaling, cyclic AMP, intracellular calcium, constitutive activity, inverse agonists, ligand binding
MeSH terms
Proto-Oncogene Mas, Amino Acid Sequence, Angiotensin I, Binding Sites, Calcium, Humans, Inositol Phosphates, Ligands, Models, Molecular, Molecular Sequence Data, Mutation, Neuropeptides, Oligopeptides, Peptide Fragments, Peptides, Protein Binding, Proto-Oncogene Proteins, Signal Transduction, Protein Structure, Secondary, Microscopy, Confocal, Intracellular Space, Receptors, G-Protein-Coupled, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review